Annual Operating Profit
-$14.42 M
-$966.00 K-7.18%
31 December 2023
Summary:
Yield10 Bioscience annual operaing income is currently -$14.42 million, with the most recent change of -$966.00 thousand (-7.18%) on 31 December 2023. During the last 3 years, it has fallen by -$4.81 million (-50.04%). YTEN annual operating profit is now -466.94% below its all-time high of $3.93 million, reached on 31 December 2012.YTEN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$3.20 M
-$763.00 K-31.27%
30 June 2024
Summary:
Yield10 Bioscience quarterly operating income is currently -$3.20 million, with the most recent change of -$763.00 thousand (-31.27%) on 30 June 2024. Over the past year, it has increased by +$500.00 thousand (+13.50%). YTEN quarterly operating profit is now -111.11% below its all-time high of $28.82 million, reached on 31 March 2012.YTEN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$12.59 M
+$464.00 K+3.55%
30 June 2024
Summary:
Yield10 Bioscience TTM operating income is currently -$12.59 million, with the most recent change of +$464.00 thousand (+3.55%) on 30 June 2024. Over the past year, it has increased by +$1.78 million (+12.39%). YTEN TTM operating profit is now -420.51% below its all-time high of $3.93 million, reached on 31 December 2012.YTEN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.2% | +13.5% | +12.4% |
| 3 y3 years | -50.0% | -3.6% | -11.1% |
| 5 y5 years | -54.7% | -60.3% | -55.9% |
YTEN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -50.0% | at low | -31.3% | +15.7% | -11.1% | +12.7% |
| 5 y | 5 years | -67.7% | at low | -60.3% | +15.7% | -55.9% | +12.7% |
| alltime | all time | -466.9% | +63.0% | -111.1% | +68.8% | -420.5% | +67.9% |
Yield10 Bioscience Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$3.20 M(+31.3%) | -$12.59 M(-3.6%) |
| Mar 2024 | - | -$2.44 M(-24.9%) | -$13.06 M(-9.4%) |
| Dec 2023 | -$14.42 M(+7.2%) | -$3.25 M(-12.3%) | -$14.42 M(+0.3%) |
| Sept 2023 | - | -$3.70 M(+1.0%) | -$14.37 M(+1.5%) |
| June 2023 | - | -$3.67 M(-3.5%) | -$14.16 M(+1.7%) |
| Mar 2023 | - | -$3.80 M(+18.6%) | -$13.93 M(+3.6%) |
| Dec 2022 | -$13.45 M(+15.0%) | -$3.20 M(-8.2%) | -$13.45 M(+1.8%) |
| Sept 2022 | - | -$3.49 M(+1.6%) | -$13.21 M(+3.1%) |
| June 2022 | - | -$3.44 M(+3.5%) | -$12.82 M(+2.8%) |
| Mar 2022 | - | -$3.32 M(+11.9%) | -$12.46 M(+6.6%) |
| Dec 2021 | -$11.69 M(+21.7%) | -$2.97 M(-4.0%) | -$11.69 M(+3.2%) |
| Sept 2021 | - | -$3.09 M(+0.3%) | -$11.33 M(+8.6%) |
| June 2021 | - | -$3.08 M(+20.7%) | -$10.44 M(+9.9%) |
| Mar 2021 | - | -$2.55 M(-2.2%) | -$9.49 M(-1.2%) |
| Dec 2020 | -$9.61 M(+11.8%) | -$2.61 M(+19.0%) | -$9.61 M(+2.1%) |
| Sept 2020 | - | -$2.19 M(+2.7%) | -$9.41 M(+2.1%) |
| June 2020 | - | -$2.14 M(-19.9%) | -$9.22 M(+2.7%) |
| Mar 2020 | - | -$2.67 M(+10.5%) | -$8.98 M(+4.5%) |
| Dec 2019 | -$8.60 M(-7.8%) | -$2.42 M(+20.9%) | -$8.60 M(+6.4%) |
| Sept 2019 | - | -$2.00 M(+5.3%) | -$8.08 M(-7.7%) |
| June 2019 | - | -$1.90 M(-16.9%) | -$8.75 M(-5.7%) |
| Mar 2019 | - | -$2.29 M(+20.6%) | -$9.29 M(-0.3%) |
| Dec 2018 | -$9.32 M(+0.4%) | -$1.90 M(-29.2%) | -$9.32 M(-6.4%) |
| Sept 2018 | - | -$2.68 M(+10.1%) | -$9.95 M(+7.5%) |
| June 2018 | - | -$2.43 M(+4.9%) | -$9.26 M(-2.9%) |
| Mar 2018 | - | -$2.32 M(-8.4%) | -$9.54 M(+2.8%) |
| Dec 2017 | -$9.28 M(-9.4%) | -$2.53 M(+27.6%) | -$9.28 M(+11.2%) |
| Sept 2017 | - | -$1.98 M(-26.9%) | -$8.35 M(-6.9%) |
| June 2017 | - | -$2.71 M(+31.5%) | -$8.97 M(+2.3%) |
| Mar 2017 | - | -$2.06 M(+29.4%) | -$8.77 M(-14.5%) |
| Dec 2016 | -$10.25 M(-17.8%) | -$1.59 M(-38.8%) | -$10.25 M(-12.8%) |
| Sept 2016 | - | -$2.60 M(+3.8%) | -$11.76 M(-4.1%) |
| June 2016 | - | -$2.51 M(-29.2%) | -$12.26 M(-22.8%) |
| Mar 2016 | - | -$3.54 M(+14.2%) | -$15.88 M(-12.6%) |
| Dec 2015 | -$12.47 M(-53.5%) | -$3.10 M(-0.1%) | -$18.17 M(-13.1%) |
| Sept 2015 | - | -$3.11 M(-49.3%) | -$20.92 M(-14.7%) |
| June 2015 | - | -$6.13 M(+5.1%) | -$24.52 M(-2.5%) |
| Mar 2015 | - | -$5.83 M(-0.4%) | -$25.16 M(-6.2%) |
| Dec 2014 | -$26.83 M(-6.0%) | -$5.85 M(-12.8%) | -$26.83 M(-8.0%) |
| Sept 2014 | - | -$6.71 M(-0.8%) | -$29.16 M(+0.8%) |
| June 2014 | - | -$6.77 M(-9.8%) | -$28.94 M(-3.6%) |
| Mar 2014 | - | -$7.50 M(-8.4%) | -$30.03 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$28.54 M(-826.4%) | -$8.18 M(+26.1%) | -$29.32 M(-3.3%) |
| Sept 2013 | - | -$6.49 M(-17.4%) | -$30.32 M(-4.0%) |
| June 2013 | - | -$7.86 M(+15.8%) | -$31.58 M(-0.3%) |
| Mar 2013 | - | -$6.79 M(-26.2%) | -$31.68 M(-906.3%) |
| Dec 2012 | $3.93 M(-110.1%) | -$9.19 M(+18.7%) | $3.93 M(+12.1%) |
| Sept 2012 | - | -$7.74 M(-2.7%) | $3.51 M(+109.9%) |
| June 2012 | - | -$7.96 M(-127.6%) | $1.67 M(-541.8%) |
| Mar 2012 | - | $28.82 M(-399.7%) | -$378.00 K(-99.0%) |
| Dec 2011 | -$38.86 M(-0.2%) | -$9.62 M(+0.4%) | -$38.86 M(+0.3%) |
| Sept 2011 | - | -$9.58 M(-4.3%) | -$38.73 M(-1.1%) |
| June 2011 | - | -$10.01 M(+3.6%) | -$39.17 M(+1.1%) |
| Mar 2011 | - | -$9.66 M(+1.9%) | -$38.74 M(-0.5%) |
| Dec 2010 | -$38.94 M(+0.5%) | -$9.48 M(-5.4%) | -$38.94 M(-0.9%) |
| Sept 2010 | - | -$10.02 M(+4.6%) | -$39.28 M(+1.3%) |
| June 2010 | - | -$9.58 M(-2.8%) | -$38.79 M(-0.9%) |
| Mar 2010 | - | -$9.86 M(+0.3%) | -$39.13 M(+1.0%) |
| Dec 2009 | -$38.73 M(-0.4%) | -$9.82 M(+3.1%) | -$38.73 M(+1.3%) |
| Sept 2009 | - | -$9.53 M(-3.9%) | -$38.25 M(-1.9%) |
| June 2009 | - | -$9.91 M(+4.8%) | -$38.98 M(+0.7%) |
| Mar 2009 | - | -$9.46 M(+1.3%) | -$38.73 M(-0.4%) |
| Dec 2008 | -$38.89 M(+15.0%) | -$9.34 M(-9.0%) | -$38.89 M(+1.9%) |
| Sept 2008 | - | -$10.27 M(+6.3%) | -$38.17 M(+1.3%) |
| June 2008 | - | -$9.65 M(+0.3%) | -$37.68 M(+1.2%) |
| Mar 2008 | - | -$9.63 M(+11.7%) | -$37.22 M(+10.1%) |
| Dec 2007 | -$33.82 M(+93.0%) | -$8.62 M(-11.9%) | -$33.81 M(+0.6%) |
| Sept 2007 | - | -$9.78 M(+6.4%) | -$33.60 M(+18.9%) |
| June 2007 | - | -$9.19 M(+47.6%) | -$28.27 M(+21.3%) |
| Mar 2007 | - | -$6.23 M(-25.9%) | -$23.29 M(+32.9%) |
| Dec 2006 | -$17.52 M(+149.5%) | -$8.40 M(+88.7%) | -$17.52 M(-4.2%) |
| Sept 2006 | - | -$4.45 M(+5.5%) | -$18.29 M(+38.5%) |
| June 2006 | - | -$4.22 M(+823.0%) | -$13.21 M(+61.4%) |
| Mar 2006 | - | -$457.00 K(-95.0%) | -$8.18 M(+16.5%) |
| Dec 2005 | -$7.03 M(+40.5%) | -$9.17 M(-1541.6%) | -$7.02 M(+25.1%) |
| Sept 2005 | - | $636.10 K(-21.2%) | -$5.61 M(+5.3%) |
| June 2005 | - | $807.50 K(+15.1%) | -$5.33 M(+2.1%) |
| Mar 2005 | - | $701.40 K(-109.0%) | -$5.22 M(+4.4%) |
| Dec 2004 | -$5.00 M(-309.8%) | -$7.76 M(-943.7%) | -$5.00 M(-281.2%) |
| Sept 2004 | - | $919.60 K(0.0%) | $2.76 M(+50.0%) |
| June 2004 | - | $919.60 K(0.0%) | $1.84 M(+100.0%) |
| Mar 2004 | - | $919.60 K | $919.60 K |
| Dec 2003 | $2.38 M(-147.1%) | - | - |
| Dec 2002 | -$5.06 M | - | - |
FAQ
- What is Yield10 Bioscience annual operaing income?
- What is the all time high annual operating profit for Yield10 Bioscience?
- What is Yield10 Bioscience annual operating profit year-on-year change?
- What is Yield10 Bioscience quarterly operating income?
- What is the all time high quarterly operating profit for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly operating profit year-on-year change?
- What is Yield10 Bioscience TTM operating income?
- What is the all time high TTM operating profit for Yield10 Bioscience?
- What is Yield10 Bioscience TTM operating profit year-on-year change?
What is Yield10 Bioscience annual operaing income?
The current annual operating profit of YTEN is -$14.42 M
What is the all time high annual operating profit for Yield10 Bioscience?
Yield10 Bioscience all-time high annual operaing income is $3.93 M
What is Yield10 Bioscience annual operating profit year-on-year change?
Over the past year, YTEN annual operaing income has changed by -$966.00 K (-7.18%)
What is Yield10 Bioscience quarterly operating income?
The current quarterly operating profit of YTEN is -$3.20 M
What is the all time high quarterly operating profit for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly operating income is $28.82 M
What is Yield10 Bioscience quarterly operating profit year-on-year change?
Over the past year, YTEN quarterly operating income has changed by +$500.00 K (+13.50%)
What is Yield10 Bioscience TTM operating income?
The current TTM operating profit of YTEN is -$12.59 M
What is the all time high TTM operating profit for Yield10 Bioscience?
Yield10 Bioscience all-time high TTM operating income is $3.93 M
What is Yield10 Bioscience TTM operating profit year-on-year change?
Over the past year, YTEN TTM operating income has changed by +$1.78 M (+12.39%)